What's Happening?
Amgen has announced multiple graduate-level internship openings for the summer of 2027 within its R&D Execution, Operations & Strategy (R&D EOS) organization. This 12-week program is designed to provide interns with both project-based and experiential
learning opportunities. The R&D EOS division focuses on advancing innovation beyond molecular science and implementing digital strategies to streamline processes within the company. Interns will be integrated into one of four functional areas: Strategy, Portfolio & Program Management, R&D Business Operations, or R&D Knowledge & Learning. Their responsibilities will include supporting key projects, collaborating with cross-functional teams to enhance R&D competitiveness, and leveraging analytical and communication skills to develop recommendations. The program culminates in presentations of their findings to executive management and participation in an intern-wide poster session. Amgen emphasizes a collaborative and inclusive culture, offering interns networking opportunities and access to employee resource groups.
Why It's Important?
This internship program is significant for several reasons. For Amgen, it represents a strategic investment in future talent, allowing the company to identify and cultivate individuals who can contribute to its mission of developing innovative medicines. By focusing on R&D EOS, Amgen aims to improve its operational efficiency and strategic execution, which can accelerate the delivery of new treatments to patients. For graduate students, it offers a valuable opportunity to gain practical experience in a leading biotechnology company, applying their academic knowledge to real-world challenges in drug development and operational strategy. The program's emphasis on digital strategies and process simplification reflects broader industry trends towards leveraging technology to enhance R&D productivity. Successful interns could potentially secure future employment with Amgen, contributing to the U.S. biotechnology sector's workforce and innovation pipeline.
What's Next?
Prospective graduate students interested in the R&D EOS internship at Amgen for Summer 2027 can apply through the company's careers portal. Amgen will continue accepting applications until a sufficient number are received or a candidate is selected. Eligible candidates must be 18 years or older, have graduated with a bachelor's degree, and be currently enrolled in an MBA, Master's, PharmD, or Ph.D. program, having completed their first year before the internship begins. The program requires interns to be located in the United States for the duration of the internship. Following the application and selection process, chosen interns will participate in the 12-week program, engaging in projects, collaborating with Amgen teams, and presenting their work. The experience gained could shape their career paths within the pharmaceutical and biotechnology industries.
Beyond the Headlines
The Amgen R&D EOS internship highlights a growing trend in the pharmaceutical industry: the increasing importance of operational excellence and strategic innovation alongside scientific discovery. While molecular science remains foundational, companies like Amgen are recognizing that efficient execution, robust portfolio management, and advanced digital strategies are crucial for bringing medicines to market faster and more effectively. This shift reflects a broader industry evolution where data science, artificial intelligence, and streamlined processes are becoming as vital as laboratory research. The program also underscores the competitive landscape for talent in the biotech sector, with companies actively recruiting and nurturing future leaders who can navigate complex R&D environments. This focus on holistic R&D capabilities, beyond just the molecule, could set new benchmarks for how pharmaceutical companies approach drug development and patient care in the coming years.













